108 related articles for article (PubMed ID: 33544616)
1. Concordance of two polymerase chain reaction-based blood group genotyping platforms for patients with sickle cell disease.
Sheppard CA; Bolen NL; Meny G; Kalvelage M; Ochoa-Garay G
Immunohematology; 2020 Dec; 36(4):123-128. PubMed ID: 33544616
[TBL] [Abstract][Full Text] [Related]
2. Performance evaluation study of ID CORE XT, a high throughput blood group genotyping platform.
López M; Apraiz I; Rubia M; Piedrabuena M; Azkarate M; Veldhuisen B; Vesga MÁ; Van Der Schoot E; Puente F; Tejedor D
Blood Transfus; 2018 Feb; 16(2):193-199. PubMed ID: 27893355
[TBL] [Abstract][Full Text] [Related]
3. Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease.
Reid ME; Halter Hipsky C; Hue-Roye K; Hoppe C
Blood Cells Mol Dis; 2014 Apr; 52(4):195-202. PubMed ID: 24309423
[TBL] [Abstract][Full Text] [Related]
4. An overview of the Progenika ID CORE XT: an automated genotyping platform based on a fluidic microarray system.
Goldman M; Núria N; Castilho LM
Immunohematology; 2015; 31(2):62-8. PubMed ID: 26495891
[TBL] [Abstract][Full Text] [Related]
5. Performance evaluation study of ID RHD XT, a new genotyping assay for the detection of high-prevalence RhD negative and weak D types.
Molano A; Apraiz I; España P; Azkarate M; Vesga MÁ; Rubia M; Piedrabuena M; Puente F; Veldhuisen B; van der Schoot E; Tejedor D; López M
Vox Sang; 2018 Oct; 113(7):694-700. PubMed ID: 30125050
[TBL] [Abstract][Full Text] [Related]
6. Red Blood Cell Antigen Genotyping for Sickle Cell Disease, Thalassemia, and Other Transfusion Complications.
Fasano RM; Chou ST
Transfus Med Rev; 2016 Oct; 30(4):197-201. PubMed ID: 27345938
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of red blood cell and platelet antigen genotyping platforms (ID CORE XT/ID HPA XT) in routine clinical practice.
Finning K; Bhandari R; Sellers F; Revelli N; Villa MA; Muñiz-Díaz E; Nogués N
Blood Transfus; 2016 Mar; 14(2):160-7. PubMed ID: 26674823
[TBL] [Abstract][Full Text] [Related]
8. A multi-centre study on the performance of the molecular genotyping platform ID RHD XT for resolving serological weak RhD phenotype in routine clinical practice.
Londero D; Monge J; Hellberg A
Vox Sang; 2020 Apr; 115(3):241-248. PubMed ID: 31912520
[TBL] [Abstract][Full Text] [Related]
9. A comparison of methods for the detection of the r'(s) haplotype.
Moulds JM; Noumsi GT; Billingsley KL
Transfusion; 2015 Jun; 55(6 Pt 2):1418-22. PubMed ID: 25496603
[TBL] [Abstract][Full Text] [Related]
10. Machine learning to optimize automated RH genotyping using whole-exome sequencing data.
Chang TC; Yu J; Wang Z; Hankins JS; Weiss MJ; Wu G; Westhoff CM; Chou ST; Zheng Y
Blood Adv; 2024 Jun; 8(11):2651-2659. PubMed ID: 38522094
[TBL] [Abstract][Full Text] [Related]
11. Clinical Utility of Genotyping Human Erythrocyte Antigens.
Wilkinson DS
Lab Med; 2016 Aug; 47(3):e28-31. PubMed ID: 27081211
[TBL] [Abstract][Full Text] [Related]
12. Weakened expression of 'e' owing to concomitant occurrence of Cys16 and Val245 (VS antigen).
Rodrigues A; Rios M; Costa FF; Saad ST; Pellegrino J; Castilho L
Vox Sang; 2004 Feb; 86(2):136-40. PubMed ID: 15023184
[TBL] [Abstract][Full Text] [Related]
13. ID CORE XT as a tool for molecular red blood cell typing.
Bonet Bub C; Castilho L
Expert Rev Mol Diagn; 2019 Sep; 19(9):777-783. PubMed ID: 31409135
[No Abstract] [Full Text] [Related]
14. Genotyping for Kidd, Kell, Duffy, Scianna, and RHCE blood group antigens polymorphisms in Jiangsu Chinese Han.
Liu Z; Zeng R; Chen Q; Li M; Shi GY; Wei P; Huang CY; Tang RC; Sun J; Zhang XG
Chin Med J (Engl); 2012 Mar; 125(6):1076-81. PubMed ID: 22613534
[TBL] [Abstract][Full Text] [Related]
15. RHD alleles among pregnant women with serologic discrepant weak D phenotypes from a multiethnic population and risk of alloimmunization.
Bub CB; Aravechia MG; Costa TH; Kutner JM; Castilho L
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28374955
[TBL] [Abstract][Full Text] [Related]
16. RHD genotyping of serologic RhD-negative blood donors in a hospital-based blood donor center.
Perez-Alvarez I; Hayes C; Hailemariam T; Shin E; Hutchinson T; Klapper E
Transfusion; 2019 Jul; 59(7):2422-2428. PubMed ID: 31059639
[TBL] [Abstract][Full Text] [Related]
17. DNA-based typing of blood groups for the management of multiply-transfused sickle cell disease patients.
Castilho L; Rios M; Bianco C; Pellegrino J; Alberto FL; Saad ST; Costa FF
Transfusion; 2002 Feb; 42(2):232-8. PubMed ID: 11896340
[TBL] [Abstract][Full Text] [Related]
18. Challenges in providing compatible blood with Rh genotype-matching in Brazilian patients with sickle cell disease.
Santos TD; Macedo MD; Menegati SFP; Gilli S; Castilho L
Transfus Med; 2019 Dec; 29(6):423-429. PubMed ID: 31631427
[TBL] [Abstract][Full Text] [Related]
19. RHD and RHCE genotyping by next-generation sequencing is an effective strategy to identify molecular variants within sickle cell disease patients.
Dezan MR; Ribeiro IH; Oliveira VB; Vieira JB; Gomes FC; Franco LAM; Varuzza L; Ribeiro R; Chinoca KZ; Levi JE; Krieger JE; Pereira AC; Gualandro SFM; Rocha VG; Mendrone-Junior A; Sabino EC; Dinardo CL
Blood Cells Mol Dis; 2017 Jun; 65():8-15. PubMed ID: 28388467
[TBL] [Abstract][Full Text] [Related]
20. A novel algorithm comprehensively characterizes human RH genes using whole-genome sequencing data.
Chang TC; Haupfear KM; Yu J; Rampersaud E; Sheehan VA; Flanagan JM; Hankins JS; Weiss MJ; Wu G; Vege S; Westhoff CM; Chou ST; Zheng Y
Blood Adv; 2020 Sep; 4(18):4347-4357. PubMed ID: 32915977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
